AMN Healthcare Services Inc (NYSE:AMN – Get Free Report) Director Mark Foletta sold 3,681 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $31.07, for a total transaction of $114,368.67. Following the completion of the sale, the director directly owned 17,917 shares of the company’s stock, valued at approximately $556,681.19. This trade represents a 17.04% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
AMN Healthcare Services Stock Down 4.2%
AMN opened at $31.01 on Friday. The stock has a market cap of $1.20 billion, a price-to-earnings ratio of -35.65, a price-to-earnings-growth ratio of 0.74 and a beta of 0.44. The company has a debt-to-equity ratio of 1.04, a quick ratio of 1.09 and a current ratio of 1.09. The firm’s fifty day moving average is $25.76 and its 200 day moving average is $20.87. AMN Healthcare Services Inc has a fifty-two week low of $14.86 and a fifty-two week high of $33.13.
AMN Healthcare Services (NYSE:AMN – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported $2.10 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.50. The business had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.23 billion. AMN Healthcare Services had a positive return on equity of 18.01% and a negative net margin of 0.95%.AMN Healthcare Services’s revenue for the quarter was up 99.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.45 EPS. On average, sell-side analysts forecast that AMN Healthcare Services Inc will post 2.7 earnings per share for the current fiscal year.
Hedge Funds Weigh In On AMN Healthcare Services
Wall Street Analysts Forecast Growth
Several brokerages recently issued reports on AMN. UBS Group lifted their target price on AMN Healthcare Services from $19.50 to $32.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Citigroup reaffirmed an “outperform” rating on shares of AMN Healthcare Services in a report on Monday, February 23rd. Robert W. Baird lifted their price objective on shares of AMN Healthcare Services from $23.00 to $26.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. BMO Capital Markets boosted their target price on shares of AMN Healthcare Services from $25.00 to $26.00 and gave the stock an “outperform” rating in a report on Monday, May 11th. Finally, Citizens Jmp boosted their target price on shares of AMN Healthcare Services from $22.00 to $24.00 and gave the stock a “market outperform” rating in a report on Monday, February 23rd. Four research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $25.29.
View Our Latest Stock Analysis on AMN Healthcare Services
About AMN Healthcare Services
AMN Healthcare Services, Inc (NYSE: AMN) is a leading provider of healthcare workforce solutions in the United States. The company specializes in staffing and recruitment services for a broad range of clinical and allied health professionals, including travel nurses, permanent placement of nursing staff, locum tenens physicians, and allied health personnel. In addition to direct staffing, AMN Healthcare offers comprehensive workforce management solutions such as vendor management systems (VMS), recruitment process outsourcing (RPO), and compliance and credentialing services through its technology platforms.
Founded in 1985 as American Mobile Nurses, the company rebranded to AMN Healthcare in 2010 to reflect its expanding portfolio of services.
See Also
- Five stocks we like better than AMN Healthcare Services
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for AMN Healthcare Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMN Healthcare Services and related companies with MarketBeat.com's FREE daily email newsletter.
